Publications by the researcher in collaboration with Angel Luis Guerrero Peral (86)

2024

  1. Acute and Preventive Treatment of COVID-19-Related Headache: A Series of 100 Patients

    Life, Vol. 14, Núm. 7

  2. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine

    Cephalalgia : an international journal of headache, Vol. 44, Núm. 4

  3. Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study

    Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202

  4. Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study

    European Journal of Neurology, Vol. 31, Núm. 5

  5. Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study

    Journal of Headache and Pain, Vol. 25, Núm. 1

  6. Improved comprehension of influenza-related headaches: Perspectives and suggestions for incidence and prevalence of headache in influenza—Response

    European Journal of Neurology

  7. Incidence and prevalence of headache in influenza: A 2010–2021 surveillance-based study

    European Journal of Neurology, Vol. 31, Núm. 8

  8. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study

    Frontiers in Neurology , Vol. 15

  9. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine

    European Journal of Neurology, Vol. 31, Núm. 4

2023

  1. Cefalea: concepto, diagnóstico, criterios de alerta y exploraciones complementarias

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 71, pp. 4143-4152

  2. Connectivity-based Meta-Bands: A new approach for automatic frequency band identification in connectivity analyses

    NeuroImage, Vol. 280

  3. Diferencias y similitudes entre la cefalea relacionada con la COVID-19 y la cefalea relacionada con la vacuna de la COVID-19. Un estudio de casos y controles

    Revista de neurologia, Vol. 77, Núm. 10, pp. 229-239

  4. Increased MRI-based Brain Age in chronic migraine patients

    Journal of Headache and Pain, Vol. 24, Núm. 1

  5. InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection

    Cephalalgia : an international journal of headache, Vol. 43, Núm. 11

  6. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

    Journal of Headache and Pain, Vol. 24, Núm. 1

  7. Long-term outcomes of nummular headache: A series of 168 patients and 1198 patient-years of follow-up

    Cephalalgia : an international journal of headache, Vol. 43, Núm. 9

  8. Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data

    Current Pain and Headache Reports

  9. Structural brain changes in patients with persistent headache after COVID-19 resolution

    Journal of Neurology, Vol. 270, Núm. 1, pp. 13-31

  10. Study about the Manchester Triage System subtriage in patients that visited the Emergency Department due to headache

    Neurologia, Vol. 38, Núm. 4, pp. 270-277

  11. Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group

    Neurologia, Vol. 38, Núm. 9, pp. 635-646